Article
Management of glioblastoma: State of the art and future directions.
CA: a cancer journal for clinicians - 1 Jul 2020
Tan Aaron C, Ashley David M, López Giselle Y, Malinzak Michael, Friedman Henry S, Khasraw Mustafa
Abstract excerpt
Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for patients with this disease is poor, with a median survival of <2 years. There is a slight predominance in males, and incidence increases with age. The standard approach to therapy in the newly diagnosed setting includes surgery followed by concurrent radiotherapy with temozolomide and further adjuvant temozolomide....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.